The prognostic value of the lymphocyte-to-monocyte ratio for high-risk papillary thyroid carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388:2783–2795. doi:10.1016/S0140-6736(16)30172-627240885
   PubMed Web of Science ®Google Scholar
• Haugen BR, EK A, KC B, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1–133.26462967
   PubMed Web of Science ®Google Scholar
• Zenan H, Zixiong L, Zhicheng Y, et al. Clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer. J Cell Physiol. 2019234(11):20584–20602. doi:10.1002/jcp.2866231016756
   PubMed Web of Science ®Google Scholar
• Chan JC, Chan DL, Diakos CI, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265:539–546. doi:10.1097/SLA.000000000000174327070934
   PubMed Web of Science ®Google Scholar
• Ahn J, Song E, Oh H-S, et al. Low lymphocyte-to-monocyte ratios are associated with poor overall survival in anaplastic thyroid carcinoma patients. Thyroid. 2019;29:824–829. doi:10.1089/thy.2018.068430864902
   PubMed Web of Science ®Google Scholar
• Jiang K, Lei J, Li C, et al. Comparison of the prognostic values of selected inflammation based scores in patients with medullary thyroid carcinoma: a pilot study. J Surg Oncol. 2017;116:281–287. doi:10.1002/jso.v116.328556902
   PubMed Web of Science ®Google Scholar
• van Velsen EFS, Stegenga MT, van Kemenade FJ, et al. Evaluating the 2015 American Thyroid Association Risk Stratification System in High Risk Papillary and Follicular Thyroid Cancer Patients. Thyroid. 2019;29:1073–1079. doi:10.1089/thy.2019.005331140385
   PubMed Web of Science ®Google Scholar
• Hay ID, Johnson TR, Thompson GB, Sebo TJ, Reinalda MS. Minimal extrathyroid extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence. Surgery. 2016;159:11–19. doi:10.1016/j.surg.2015.05.04626514317
   PubMed Web of Science ®Google Scholar
• Lei J, Zhong J, Jiang K, Li Z, Gong R, Zhu J. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma. Oncotarget. 2017;8:27022–27033. doi:10.18632/oncotarget.1538828223546
   PubMedGoogle Scholar
• Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12:646–653. doi:10.1038/nrendo.2016.11027418023
   PubMed Web of Science ®Google Scholar
• Nishijima TF, Muss HB, Shachar SS, Tamura K, Takamatsu Y. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41:971–978. doi:10.1016/j.ctrv.2015.10.00326481060
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–899. doi:10.1016/j.cell.2010.01.02520303878
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer. Nat Immunol. 2017;18:843–850. doi:10.1038/ni.375428722707
   PubMed Web of Science ®Google Scholar
• Ray-Coquard I, Cropet C, Van Glabbeke M, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009;69:5383–5391. doi:10.1158/0008-5472.CAN-08-384519549917
   PubMed Web of Science ®Google Scholar
• Ceze N, Thibault G, Goujon G, et al. Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy. Cancer Chemother Pharmacol. 2011;68:1305–1313. doi:10.1007/s00280-011-1610-321448592
   PubMed Web of Science ®Google Scholar
• Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 2014;6:1670–1690. doi:10.3390/cancers603167025125485
   PubMed Web of Science ®Google Scholar
• Goswami KK, Ghosh T, Ghosh S, Sarkar M, Bose A, Baral R. Tumor promoting role of anti-tumor macrophages in tumor microenvironment. Cell Immunol. 2017;316:1–10. doi:10.1016/j.cellimm.2017.04.00528433198
   PubMed Web of Science ®Google Scholar
• Gu L, Li H, Chen L, et al. Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget. 2016;7:31926–31942. doi:10.18632/oncotarget.787626942464
   PubMedGoogle Scholar
• Vaisman F, Momesso D, Bulzico DA, et al. Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clin Endocrinol (Oxf). 2012;77:132–138. doi:10.1111/j.1365-2265.2012.04342.x22248037
   PubMed Web of Science ®Google Scholar
• Pitoia F, Bueno F, Urciuoli C, Abelleira E, Cross G, Tuttle RM. Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems. Thyroid. 2013;23:1401–1407. doi:10.1089/thy.2013.001123517313
   PubMed Web of Science ®Google Scholar
• Tuttle RM, Tala H, Shah J, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010;20:1341–1349. doi:10.1089/thy.2010.017821034228
   PubMed Web of Science ®Google Scholar
• Li J, Zhou J, Yang P-H, et al. Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma. Eur J Cancer. 2016;62:86–95. doi:10.1016/j.ejca.2016.04.01127232330
   PubMed Web of Science ®Google Scholar
• Conzo G, Docimo G, Mauriello C, et al. The current status of lymph node dissection in the treatment of papillary thyroid cancer. A literature review. Clin Ter. 2013;164:e343–e346. doi:10.7417/CT.2013.159924045534
   PubMed Web of Science ®Google Scholar
• Conzo G, Calò PG, Gambardella C, et al. Controversies in the surgical management of thyroid follicular neoplasms. Retrospective analysis of 721 patients. Int J Surg. 2014;12 Suppl 1:S29–S34. doi:10.1016/j.ijsu.2014.05.013
   PubMed Web of Science ®Google Scholar
• Peng D, Lu J, Hu H, Li B, Ye X, Cheng N. Lymphocyte to monocyte ratio predicts resectability and early recurrence of Bismuth-Corlette type IV Hilar Cholangiocarcinoma. J Gastrointest Surg. 2019. doi:10.1007/s11605-018-04086-9
   Web of Science ®Google Scholar
• Jin F, Han A, Shi F, Kong L, Yu J. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer. Onco Targets Ther. 2016;9:6529–6537. doi:10.2147/OTT.S11729027799800
   PubMed Web of Science ®Google Scholar